Silihan lan utang jangka dawa perusahaan ABVC BioPharma Inc (ABVC)

This chart of ABVC BioPharma (ABVC) stock quotes reflects the dynamics of long-term debt, which stands at 0.00. Global geopolitical tensions are hindering international trials of new treatment methods and disrupting the transportation of biomaterials. Meanwhile, the company is attracting biochemists through a flexible approach to CNS research. A lack of market influence and low trading volumes are forcing the firm to seek licensing partners to monetize its patents.

For ABVC BioPharma, whose oncology developments remain independent of economic cycles, the company's long-term debt figure on GURU.Markets reflects the scale of capital raised for multi-year clinical trials. This indicator aggregates all liabilities with a maturity of over one year, allowing investors to assess the balance between long-term financial stability and the intensity of the investment program for developing new drugs.